[go: up one dir, main page]

SV2011003784A - Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida - Google Patents

Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida

Info

Publication number
SV2011003784A
SV2011003784A SV2011003784A SV2011003784A SV2011003784A SV 2011003784 A SV2011003784 A SV 2011003784A SV 2011003784 A SV2011003784 A SV 2011003784A SV 2011003784 A SV2011003784 A SV 2011003784A SV 2011003784 A SV2011003784 A SV 2011003784A
Authority
SV
El Salvador
Prior art keywords
nifurtimox
treatment
diseases caused
trichomonadida
trichomones
Prior art date
Application number
SV2011003784A
Other languages
English (en)
Inventor
Achim Harder
Gisela Greif
Robrecht Froyman
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of SV2011003784A publication Critical patent/SV2011003784A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE AL USO DE NIFURTIMOX PARA EL TRATAMIENTO DE ENFERMEDADES CAUSADAS POR TRICOMONAS, TALES COMO, POR EJEMPLO, LA HISTOMONIASIS, PARTICULARMENTE EN PAVOS
SV2011003784A 2008-07-02 2011-01-03 Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida SV2011003784A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102008031283A DE102008031283A1 (de) 2008-07-02 2008-07-02 Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten

Publications (1)

Publication Number Publication Date
SV2011003784A true SV2011003784A (es) 2011-05-20

Family

ID=41092164

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2011003784A SV2011003784A (es) 2008-07-02 2011-01-03 Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida

Country Status (26)

Country Link
US (1) US8440613B2 (es)
EP (1) EP2310017B1 (es)
JP (1) JP5571659B2 (es)
KR (1) KR20110031360A (es)
CN (1) CN102083440B (es)
AR (1) AR072426A1 (es)
AU (1) AU2009266124B2 (es)
CA (1) CA2729727A1 (es)
CL (1) CL2010001594A1 (es)
CO (1) CO6321268A2 (es)
CR (1) CR20110023A (es)
DE (1) DE102008031283A1 (es)
DK (1) DK2310017T3 (es)
DO (1) DOP2010000406A (es)
EC (1) ECSP10010721A (es)
ES (1) ES2415231T3 (es)
IL (1) IL209999A0 (es)
MX (1) MX2010014444A (es)
NI (1) NI201100009A (es)
PE (1) PE20110370A1 (es)
PL (1) PL2310017T3 (es)
RU (1) RU2538712C2 (es)
SV (1) SV2011003784A (es)
UA (1) UA103197C2 (es)
WO (1) WO2010000398A1 (es)
ZA (1) ZA201009226B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2633855A1 (en) 2012-03-01 2013-09-04 Veterinärmedizinische Universität Wien Protease inhibitors for treating Trichomonas gallinae infections
US10081656B2 (en) * 2015-05-20 2018-09-25 Merial, Inc. Anthelmintic depsipeptide compounds
HUE065907T2 (hu) 2015-12-28 2024-06-28 Boehringer Ingelheim Vetmedica Gmbh Anthelmintikus hatású depszipeptid vegyületek
JP6085706B1 (ja) * 2016-03-31 2017-02-22 株式会社ポーラファルマ 抗トリトリコモナス剤
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170957B (de) * 1962-11-23 1964-05-27 Bayer Ag Verfahren zur Herstellung von 5-Nitro-furfuryliden-(2)-iminoderivaten
NO176766C (no) * 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
ES2166359T3 (es) 1992-03-17 2002-04-16 Fujisawa Pharmaceutical Co Derivado de depsipeptido, su produccion y uso.
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
EP0685469A4 (en) 1993-02-19 1996-04-03 Meiji Seika Kaisha DERIVATIVE OF PF 1022 USED AS A CYCLIC DEPSIPEPTIDE.
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
US5646244A (en) 1993-09-06 1997-07-08 Fujisawa Pharmaceutical Co., Ltd. Cyclodepsipeptide compound
DE4401389A1 (de) * 1994-01-19 1995-07-20 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 12 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 12 Ringatomen und Verfahren zu ihrer Herstellung
DE4406025A1 (de) 1994-02-24 1995-08-31 Bayer Ag Milchsäure-haltige cyclische Depsipeptide mit 18 Ringatomen als endoparasitizide Mittel und Verfahren zu ihrer Herstellung
DE4437198A1 (de) 1994-10-18 1996-04-25 Bayer Ag Verfahren zur Sulfonylierung, Sulfenylierung und Phosphorylierung von cyclischen Depsipeptiden
JP3985050B2 (ja) * 1995-06-30 2007-10-03 アステラス製薬株式会社 デプシペプチド誘導体その製造法およびその新規中間体
CA2232668C (en) 1995-09-22 2011-10-18 Meiji Seika Kaisha, Ltd. Novel derivatives of cyclodepsipeptide pf1022 substance
DE19545639A1 (de) * 1995-12-07 1997-06-12 Bayer Ag Verfahren zur Herstellung von substituierten Arylmilchsäure-haltigen Cyclodepsipeptiden mit 24 Ringatomen
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
UA5478U (uk) * 2004-06-21 2005-03-15 Ігор Едуардович Лук'янов Спосіб лікування хворих на урогенітальний трихомоніаз
KR20070086000A (ko) * 2004-11-12 2007-08-27 셀진 코포레이션 기생충성 질병의 치료 및 관리를 위한 면역조절성 화합물을사용하는 방법 및 조성물

Also Published As

Publication number Publication date
PE20110370A1 (es) 2011-06-22
MX2010014444A (es) 2011-02-22
WO2010000398A1 (de) 2010-01-07
ES2415231T3 (es) 2013-07-24
RU2011103476A (ru) 2012-08-10
PL2310017T3 (pl) 2013-08-30
DK2310017T3 (da) 2013-07-01
CN102083440B (zh) 2013-03-27
ECSP10010721A (es) 2011-01-31
IL209999A0 (en) 2011-02-28
EP2310017B1 (de) 2013-05-15
JP5571659B2 (ja) 2014-08-13
US8440613B2 (en) 2013-05-14
UA103197C2 (uk) 2013-09-25
CO6321268A2 (es) 2011-09-20
JP2011526264A (ja) 2011-10-06
AR072426A1 (es) 2010-08-25
ZA201009226B (en) 2012-03-23
NI201100009A (es) 2011-08-10
DOP2010000406A (es) 2011-01-15
CA2729727A1 (en) 2010-01-07
AU2009266124A1 (en) 2010-01-07
KR20110031360A (ko) 2011-03-25
CR20110023A (es) 2011-05-10
DE102008031283A1 (de) 2010-01-07
CN102083440A (zh) 2011-06-01
AU2009266124B2 (en) 2015-03-19
CL2010001594A1 (es) 2011-05-06
US20110118176A1 (en) 2011-05-19
RU2538712C2 (ru) 2015-01-10
EP2310017A1 (de) 2011-04-20

Similar Documents

Publication Publication Date Title
AR091837A1 (es) Compuestos para inmunoterapia dirigida
CL2016001733A1 (es) Compuestos intermediarios para la preparación de compuestos derivados de piperidinona como inhibidores mdm2 para el tratamiento de cáncer div. sol. 3415-12.
ECSP14013339A (es) Compuestos con actividad nematicida
GT201400086A (es) Compuestos con actividad nematicida
MX2019003738A (es) Compuestos antivirales.
ECSP14017269A (es) Compuestos para tratar la atrofia muscular espinal
CO6771447A2 (es) Ciclopropilaminas como inhibidores de desmetilasa 1 específica de lisina
DOP2010000270A (es) Derivados de azetidina y ciclobutano como inhibidores de jak
GT201500138A (es) Novedososo derivados de bencimidazol como antagonistas de ep4
GT201200016A (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
CL2012001714A1 (es) Compuestos derivados de pirrol[3.4-b]piridin-5-ona, inhibidores de pi3k; composicion farmaceutica que los comprende; y uso para el tratamiento de enfermedades tales como alzheimer, epilepsia, esclerosis multiple, parkinson, entre otras.
PA8740901A1 (es) Compuestos organicos
AR089993A1 (es) Macrociclos peptidomimeticos
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
UY33627A (es) Compuestos para tratar enfermedades neurodegenerativas
CR20140071A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
CO6721019A2 (es) Quinazolincarboxamida azetidinas
CL2012003681A1 (es) Compuestos derivados de piperidina; composicion farmaceutica; y su uso como inhibidores de acetil-coa carboxilasa para el tratamiento de trastornos metabolicos, tales como obesidad y diabetes.
NI201100155A (es) Composiciones y métodos para el tratamiento prolongado con aminopiridinas
ECSP14002542A (es) Nuevos 2h–indazoles como antagonistas del receptor ep2
IN2014MN01469A (es)
SV2011003784A (es) Nifurtimox para el tratamiento de enfermedades causadas por trichomonadida
BR112013027222A2 (pt) composição de liberação prolongada que contém peptídeos como ingrediente ativo
DOP2015000007A (es) Métodos para preparar triazolopiridinas sutituidas
CR20120166A (es) Composiciones y productos antimicrobianos